Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportu - MarketsandMarkets

Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportu

Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportu - MarketsandMarkets
Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportu
Published Oct 26, 2012
392 pages — Published Oct 26, 2012
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the status of a disease. These nucleic acids or proteins, which belong to individual patients or foreign organisms, help determine a specific therapy, or risk of developing a specific disease, or other health conditions. MDx is the fastest growing segment within the in-vitro diagnostic (IVD) space, driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost-effective testing. Owing to these factors, the molecular diagnostics market crossed $4.8 billion in 2011, and is poised to grow at a CAGR of 9.1% in the next five years.

MDx involves instruments and reagents that leverage multiple technologies to identify genetic variations. The technologies utilized in molecular diagnostics include polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization (In-situ Hybridization & fluorescence in situ hybridization (FISH)), DNA Sequencing, next generation sequencing (NGS), microarrays, and others.

Molecular diagnostics has applications in infectious disease molecular testing, oncology, blood screening, genetic testing, DNA fingerprinting (e.g., paternity testing, forensic testing), microbiology, tissue typing, and food pathogen detection testing. The booming MDx areas are molecular tests for women's health, oncology, and organ transplant testing.

North America dominated the molecular diagnostics market in 2011; the U.S. is the prime market for molecular diagnostics companies due to the availability of government funds, rising incidence of chronic diseases related to the aging population, and high awareness of pharmacogenomics/personalized medicine. In addition, major local companies have easy access to this market, which makes the U.S. the largest and most significant market for suppliers. Europe is still suffering from the economic downturn and the Eurozone crisis and it is predicted that customers will delay purchases of capital equipments; this is expected to hamper the growth of this market, albeit for a short term. The Asian market, however, shows greater opportunities with the highest CAGR due to increased purchasing power, an emerging mindset toward wellness, preventive medicine, and increased access to cutting-edge products and services.

Factors like increase in awareness and acceptance of personalized medicine, advancements in molecular techniques, and increasing investments in genomics & proteomics research will spur the molecular diagnostics market in the future. Yet, reimbursement issues for non-coded tests and complex regulatory framework will restrict the growth of this market.

Molecular diagnostic tools have a vast base of end-users, which includes hospital-based laboratories, reference laboratories, and others (physicians' labs, research laboratories, other healthcare clinics, and government agencies). Hospitals offer the major chunk of business for MDx companies; however, reference laboratories are growing at a high CAGR and are driving the market, as they perform complex tests and offer expertise to small hospitals setups, clinical researchers, and insurance companies.

Although the market for molecular diagnostics is fragmented with more than 500 companies, the most prominent players are Roche Diagnostics (Switzerland), Novartis (Switzerland), Gen-Probe (U.S.), Qiagen (The Netherlands), Abbott Diagnostics (U.S.), Becton Dickinson (U.S.) and Cepheid (U.S.), to name a few.

Scope of the Report

This research report categorizes the global molecular diagnostics market into application, technology, and product type. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to

  
Source:
Document ID
MD 1296
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Increasing awareness and acceptance of personalized medicine and companion diagnostics
3.3.1.2 Development of biomarker identification and advancements in molecular techniques
3.3.1.3 Proteomics and genomics technology research to goad molecular testing market
3.3.1.4 Increase in aging population demands growth of molecular diagnostics
3.3.2 RESTRAINTS
3.3.2.1 Increased cost with new & complex platforms demand skilled labor & mandatory training
3.3.2.2 Reimbursement issues
3.3.2.3 Complex regulatory framework to delay approvals of new molecular diagnostic tests
3.3.3 OPPORTUNITIES
3.3.3.1 Extending reach of molecular diagnostics
3.3.3.2 Emerging technologies can soon gain importance in molecular diagnostic tests
3.4 MARKET SHARE ANALYSIS
3.5 END-USER ANALYSIS
3.6 EFFECTS OF OBAMACARE ON THE MOLECULAR DIAGNOSTICS MARKET

4 GLOBAL MARKET, BY APPLICATION
4.1 INTRODUCTION
4.2 INFECTIOUS DISEASES
4.2.1 HEPATITIS B VIRUS (HBV)
4.2.2 HEPATITIS C VIRUS (HCV)
4.2.3 HUMAN IMMUNODEFICIENCY VIRUS (HIV)
4.2.4 TUBERCULOSIS (TB)
4.2.5 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG)
4.2.6 HUMAN PAPILLOMAVIRUS (HPV)
4.2.7 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
4.2.8 OTHERS
4.3 ONCOLOGY
4.3.1 PROSTATE
4.3.2 BREAST
4.3.3 COLORECTAL
4.3.4 OTHERS
4.4 GENETICS
4.5 BLOOD SCREENING
4.6 MICROBIOLOGY
4.7 OTHERS

5 GLOBAL MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 POLYMERASE CHAIN REACTION (PCR)
5.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
5.4 MICROARRAY
5.5 HYBRIDIZATION (IN SITU HYBRIDIZATION AND FLUORESCENCE IN SITU HYBRIDIZATION)
5.6 DNA SEQUENCING & NEXT-GENERATION SEQUENCING
5.7 OTHERS

6 GLOBAL MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION
6.2 INSTRUMENTS
6.3 REAGENTS
6.4 SERVICES

7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.3.1 U.K.
7.3.2 GERMANY
7.3.3 FRANCE
7.3.4 ITALY
7.3.5 SPAIN
7.3.6 REST OF EUROPE
7.4 ASIA
7.4.1 JAPAN
7.4.2 INDIA
7.4.3 CHINA
7.4.4 REST OF ASIA
7.5 REST OF THE WORLD (ROW)
7.5.1 LATIN AMERICA
7.5.2 PACIFIC
7.5.3 MIDDLE EAST & AFRICA

8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS & ACQUISTIONS
8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
8.4 NEW PRODUCT LAUNCH
8.5 APPROVALS
8.6 EXPANSION
8.7 OTHERS

9 COMPANY PROFILES
9.1 AB

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportu" Oct 26, 2012. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Molecular-Diagnostics-Market-Technologies-PCR-DNA-Sequencing-Microarray-Transcription-Mediated-Amplification-Hybridization-Applications-Virology-Infectious-Diseases-Cancer-Oncology-Genetic-Testing-Blood-Screening-Microbiology-Global-Opportu-2144-357>
  
APA:
MarketsandMarkets. (2012). Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportu Oct 26, 2012. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Molecular-Diagnostics-Market-Technologies-PCR-DNA-Sequencing-Microarray-Transcription-Mediated-Amplification-Hybridization-Applications-Virology-Infectious-Diseases-Cancer-Oncology-Genetic-Testing-Blood-Screening-Microbiology-Global-Opportu-2144-357>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.